Market leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
Expert views
PolyPetide’s Approach to Process Intensification: Tackling the increasing Peptide Demand
27 Nov 2025 - Presented at TIDES Europe, 12 November 2025 Speaker: Francesco Terzani, Scientist Innovation Abstract: The global rise in peptide demand, driven by accelerated clinical development and speed to […]
Read moreBusiness news
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
28 Oct 2025 - Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global leader in peptide contract […]
Read more
